newsfilter
← Latest News
GlobeNewswire·

Alaunos Therapeutics Announces Pricing of Public Offering of Common Stock

HOUSTON, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. ("Alaunos" or the "Company") (NASDAQ:TCRT), a clinical-stage oncology-focused cell therapy company, today announced the pricing of its underwritten